A STUDY OF PREVALENCE OF HYPERURICEMIA & METABOLIC SYNDROME & THEIR ASSOCIATION IN TYPE 2 DIABETES MELLITUS IN DSP HOSPITAL

Dr. Swagat Mohanty, Dr. Soumitra Chakroborty, Dr. Soubhik Roy, Dr. Debarshi Jana

Abstract


Diabetes is a syndrome of hyperglycemia and disturbances of carbohydrate, fat and protein metabolism associated with absolute or relative deficiencies in insulin secretion.

To find our correlation between hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus.

300 patients of type 2 diabetes were selected at Department of Medicine , DSP hospital from October 2017 to September 2018.

The results demonstrate the prevalence of metabolic syndrome in type 2 diabetes as 55%.Increased serum uric acid levels were also significantly associated with occurrence of metabolic syndrome in diabetic patients.

Physicians should recognize the metabolic syndrome and hyperuricemia as a frequent co-morbidity of Diabetes and treat it to prevent serious complications.


Keywords


Type 2 diabetes mellitus, hyperuricemia and Metabolic Syndrome

Full Text:

PDF

References


Dedwania PC, Gupta R. Management issues in metabolic syndrome. J Assoc Physicians India. 2006; 54:797-810.

Chen LY, Zhu WH, Chen ZW, Dai HL, Ren JJ, Chen JH, Chen LQ, Fang LZ. Relationship between hyperuricemia and metabolic syndrome. Journal of Zhejiang University Science B. 2007 Jul 1;8(8):593-8.

Bengtsson C, Lappidus L, Stendahal C, Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and over all death. Acta Med Scand. 2002; 224:549-55.

Nakagawa T, Cirillo P, Sato W, Gersch M, Sautin Y, Roncal C. The conundrum of hyperuricemia, metabolic syndrome and renal disease. Intern Emerg Med. 2008;3(4):313-8.

Reihmann M, Schutte A, Malan L, Huismann H, and Malan N. Hyperuricemia is an independent factor for metabolic syndrome in a sub- Saharan African population. A factor analysis. Atherosclerosis 2008 Apr;197(2):638-45.

Nayak RC, Omar MAK, Rabizadeh A. Srikanta S, Eisenbarth GS: "Cytoplasmic" islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Dlabetes 34:617-19. 1985

Longo DL, Fauci AS, Kasper DL, Jameson JL, Hauser SL, Loscalzo J, et al. Harrison's Principles Of Internal Medicin.2012; 18 (2):2969.

Cragg SJ, Drysdale J, Worwood M. Genes for the 'H' subunit of human ferritin are present on a number of human chromosomes. Hum Genet. 1985;71(2):108–112.

Prior, I. A. M., et al. "Hyperuricemia, gout, and diabetic abnormality in Polynesian people." The Lancet 287.7433 (1966): 333-338.

Cai Z, Xu X, Wu X, Zhou C, Li D. Hyperuricemia and Metabolic Syndrome. Asia Pac J Clin Nutr 2009;18 (1) : 81-87

Chen LY, Jhu WH, Chen ZW, Di HL, Reh JJ.Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 2007 Aug; 8(8):593-598.

Anthonia O Ogbera and Alfred O Azenabor. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr. 2010; 2: 24.

Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic Syndroma in Urban asian Indian adults- A Population Study using Modified ATP III criteria. Diab Res and clin Prac vol 2003 June;60(3):199-204.

Misra A, Wasir JA Pandey RM. Evaluation of candidate definitions of metabolic syndrome in adult Asian Indians. Diabetes Care 2005 ; 28(2) : 398-403.

Eliaseson B, Cederholm J, Nilsson P. The gap between guidelines andreality. Type 2 diabetes in a national diabetes register 1996 - 2003 Diabet Med 2005 ; 22 (10) : 1420-6.

Conen, D., Wietlisbach, V., Bovet, P., Shamlaye, C., Riesen, W., Paccaud, F., Burnier, M et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.2004 Mar 25;4:9.

Schachter, M.2005. Uric acid and hypertension.Curr. Pharm. Des., 11(32):4139-4143.

Tuomilehto J, Wolf E, Talyor R, Ram P, King H.Plasma uric acid levels and its association with diabetes mellitus and some biologic parameters in biracial population of Fiji. American journal o f epidemiology1988,127(2):321-336.

Mundhe SA, Mhasde DR. The study of prevalence of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus. International Journal. 2016 Apr;3(2):241.

Bonakdaran S, Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes. Current diabetes reviews. 2014 Mar 1;10(2):113-7.

Anthonia O Ogbera and Alfred O Azenabor. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr. 2010; 2: 24.

Bo, S., Cavallo-Perin, P., Gentile, L., Repetti, E., Pagano, G.Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.. Diabetes Metab.2001 Feb;27(1):31-35.

Rho, Y.H., Choi, S.J., Lee, Y.H., Ji, J.D., Choi, K.M., Baik, S.H., Chung, S.H., Kim, C.G., Choe, J.Y., Lee, S.W., et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J. Korean Med.Sci. 2005; 20(6):1029-1033.

Schmidt, M.I., Watson, R.L., Duncan, B.B., Metcalf, P., Brancati, F.L., Sharrett, A.R., Davis, C.E., Heiss, G. Clustering of dyslipidemia,hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.Metabolism.1996;45(6):699-706.

Yoo, T.W., Sung, K.C., Shin, H.S., Kim, B.J., Kim, B.S., Kang, J.H., Lee, M.H., Park, J.R., Kim, H., Rhee, E.J., et 156]al.Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ. J.2005;69(8):928-933.


Refbacks

  • There are currently no refbacks.